MA71611A - Nouveaux inhibiteurs de l'acc - Google Patents

Nouveaux inhibiteurs de l'acc

Info

Publication number
MA71611A
MA71611A MA71611A MA71611A MA71611A MA 71611 A MA71611 A MA 71611A MA 71611 A MA71611 A MA 71611A MA 71611 A MA71611 A MA 71611A MA 71611 A MA71611 A MA 71611A
Authority
MA
Morocco
Prior art keywords
acc inhibitors
new acc
new
inhibitors
acc
Prior art date
Application number
MA71611A
Other languages
English (en)
Inventor
Brian Stephen Gerstenberger
Chulho Choi
Daniel Copley Schmitt
Mihir Dineshkumar PARIKH
Robert Lee Dow
Gajendra Ingle
Scott William Bagley
Andrea Nicole BOOTSMA
David James EDMONDS
Carmen Noemi GARCIA-IRIZARRY
Jessica Gloria Katherine O'Brien
Gwenaella Christine RESCOURIO
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of MA71611A publication Critical patent/MA71611A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
MA71611A 2022-07-29 2023-07-26 Nouveaux inhibiteurs de l'acc MA71611A (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263393712P 2022-07-29 2022-07-29
EP23754416.8A EP4562017B1 (fr) 2022-07-29 2023-07-26 Nouveaux inhibiteurs d'acc
PCT/IB2023/057576 WO2024023727A1 (fr) 2022-07-29 2023-07-26 Nouveaux inhibiteurs de l'acc

Publications (1)

Publication Number Publication Date
MA71611A true MA71611A (fr) 2025-05-30

Family

ID=87571535

Family Applications (1)

Application Number Title Priority Date Filing Date
MA71611A MA71611A (fr) 2022-07-29 2023-07-26 Nouveaux inhibiteurs de l'acc

Country Status (19)

Country Link
US (1) US12655157B2 (fr)
EP (1) EP4562017B1 (fr)
JP (1) JP7734874B2 (fr)
KR (1) KR20250037569A (fr)
CN (1) CN120019059A (fr)
AR (1) AR130069A1 (fr)
AU (1) AU2023316863A1 (fr)
CA (1) CA3263179A1 (fr)
CL (1) CL2025000240A1 (fr)
CO (1) CO2025000972A2 (fr)
CR (1) CR20250035A (fr)
DK (1) DK4562017T3 (fr)
DO (1) DOP2025000009A (fr)
IL (1) IL318404A (fr)
MA (1) MA71611A (fr)
MX (1) MX2025001176A (fr)
PY (1) PY2359799A (fr)
TW (1) TWI860797B (fr)
WO (1) WO2024023727A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025133948A1 (fr) * 2023-12-21 2025-06-26 Pfizer Inc. Inhibiteurs de l'acétyl coa-carboxylase (acc)
CN119876334B (zh) * 2025-03-21 2025-06-24 北京索莱宝科技有限公司 乙酰辅酶a羧化酶的酶活测定方法、试剂盒与应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0166088B1 (ko) 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
US5376645A (en) 1990-01-23 1994-12-27 University Of Kansas Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
GB9518953D0 (en) 1995-09-15 1995-11-15 Pfizer Ltd Pharmaceutical formulations
WO2000035298A1 (fr) 1996-11-27 2000-06-22 Wm. Wrigley Jr. Company Chewing-gum contenant des agents medicamenteux actifs
GB9711643D0 (en) 1997-06-05 1997-07-30 Janssen Pharmaceutica Nv Glass thermoplastic systems
PE20081559A1 (es) * 2007-01-12 2008-11-20 Merck & Co Inc DERIVADOS DE ESPIROCROMANONA SUSTITUIDOS COMO INHIBIDORES DE ACETIL CoA CARBOXILASA
EP2123652A1 (fr) 2007-02-20 2009-11-25 Takeda Pharmaceutical Company Limited Composé hétérocyclique
AU2008223348A1 (en) 2007-03-07 2008-09-12 Alantos Pharmaceuticals Holding, Inc. Metalloprotease inhibitors containing a heterocyclic moiety
JP5435592B2 (ja) 2008-05-28 2014-03-05 ファイザー・インク ピラゾロスピロケトンアセチルCoAカルボキシラーゼ阻害剤
UA102336C2 (uk) * 2009-11-10 2013-06-25 Пфайзер Інк. N1-ПІРАЗОЛСПІРОКЕТОНИ ЯК ІНГІБІТОРИ АЦЕТИЛ-СоА-КАРБОКСИЛАЗ
CN103189377B (zh) * 2010-10-29 2015-02-25 辉瑞大药厂 N1/n2-内酰胺乙酰辅酶a羧化酶抑制剂
IN2014MN02652A (fr) 2012-06-08 2015-08-21 Gilead Sciences Inc
MX2016002479A (es) 2013-09-12 2016-05-31 Pfizer Uso de inhibidores de acetil-coa carboxilasa para tratar acne vulgaris.
CN116003321A (zh) 2018-05-09 2023-04-25 北京加科思新药研发有限公司 可用作shp2抑制剂的新型杂环衍生物
AU2019385438A1 (en) 2018-11-20 2021-05-27 The National Institutes of Pharmaceutical R&D Co., Ltd. Spiro compound and medical uses thereof
WO2021026672A1 (fr) 2019-08-09 2021-02-18 Novartis Ag Inhibiteurs hétérocycliques de wdr5 utilisés en tant que composés anticancéreux

Also Published As

Publication number Publication date
EP4562017A1 (fr) 2025-06-04
KR20250037569A (ko) 2025-03-17
IL318404A (en) 2025-03-01
TW202415668A (zh) 2024-04-16
EP4562017B1 (fr) 2026-07-01
US12655157B2 (en) 2026-06-16
PY2359799A (es) 2024-02-02
CL2025000240A1 (es) 2025-05-09
MX2025001176A (es) 2025-03-07
CO2025000972A2 (es) 2025-02-13
CA3263179A1 (fr) 2024-02-01
AR130069A1 (es) 2024-10-30
DOP2025000009A (es) 2025-04-08
TWI860797B (zh) 2024-11-01
DK4562017T3 (da) 2026-07-20
JP7734874B2 (ja) 2025-09-05
US20240109915A1 (en) 2024-04-04
WO2024023727A1 (fr) 2024-02-01
CR20250035A (es) 2025-03-18
AU2023316863A1 (en) 2025-02-13
JP2025524984A (ja) 2025-08-01
CN120019059A (zh) 2025-05-16

Similar Documents

Publication Publication Date Title
MA56507A (fr) Nouveaux inhibiteurs d'egfr
CA3263179A1 (fr) Nouveaux inhibiteurs de l'acc
EP4502091A4 (fr) Composition de polissage
EP4267598A4 (fr) Nouvelles protéines inhibitrices d'insectes
EP4337203A4 (fr) Inhibiteurs de l'interaction ménine-mll
EP4288099A4 (fr) Nouveaux anticorps anti-cd24
EP4216330C0 (fr) Système de formation
EP4363445A4 (fr) Nouveaux anticorps anti-masp-2
EP4405334C0 (fr) Inhibiteurs de la sortiline
KR102515823B9 (ko) 음악 분수 시스템
CA3251998A1 (fr) Nouveaux anticorps masqués
JP1779708S (ja) ジャケット
EP4503097A4 (fr) Composition de polissage
EP4499106A4 (fr) Inhibiteurs nucléosidiques de line-1
EP4367107A4 (fr) Nouveaux composés utiles comme inhibiteurs de pcsk9
EP4745526A1 (fr) Système de recommandation de destination
EP4744570A1 (fr) Laryngoscope vidéo
UA159477U (uk) Тактичний кейс
JP1823581S (ja) 交番
JP1796047S (ja) 交番
JP1795943S (ja) 交番
JP1795944S (ja) 交番
JP1779707S (ja) ジャケット
JP1783743S (ja) ジャケット
JP1770941S (ja) ジャケット